Valproic acid for myoclonic epilepsy in POLG1 carriers can be fatal
With interest we read the article by Tarka et al. about the autopsy findings of an 8-year-old female with mitochondrial disorder (MID) due to the compound heterozygous variants c.2243G>C and c.2542G>A in POLG1 [1]. The patient manifested clinically with mental retardation, developmental regres...
Main Author: | Josef Finsterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2021-03-01
|
Series: | Folia Neuropathologica |
Subjects: | |
Online Access: | https://www.termedia.pl/Valproic-acid-for-myoclonic-epilepsy-in-POLG1-carriers-can-be-fatal,20,43535,1,1.html |
Similar Items
-
POLG gene mutation. Clinico-neuropathological study
by: Sylwia Tarka, et al.
Published: (2021-01-01) -
Reversible Valproate Hepatotoxicity and Associated Mitochondrial Disease
by: J Gordon Millichap
Published: (2008-02-01) -
POLG Novel Mutation with Alpers Syndrome
by: J Gordon Millichap
Published: (2012-02-01) -
EPILEPSY IN CHILDREN WITH MYTOCHONDRIAL DISEASES: DIAGNOSTICS AND TREATMENT FEATURES
by: N. N. Zavadenko, et al.
Published: (2016-09-01) -
ALPERS-HUTTENLOCHER SYNDROME
by: T. T. Batysheva, et al.
Published: (2016-05-01)